Ramkrishna Sadhukhan

Author

AbbVie (United States)

Also Known As

R Sadhukhan, R. K. Sadhukhan, R. Sadhukhan, Ramkrishna Sadhukhan

Publications

671

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)Cleveland Clinic Abbott Fund Cleveland Foundation Abbott (United Kingdom)

About

Ramkrishna Sadhukhan is an author at AbbVie (United States) specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	144
2	Natural Sciences	5	5	139
3	Biochemistry	5	5	139
4	Engineering	2	2	180
5	Biology	1	1	19

Ramkrishna Sadhukhan

Publications

651

Citations

H-Index

Page 1

	Year	Citations
Purification, characterization and antitumor activity of l-asparaginase isolated from Pseudomonas stutzeri MB-405 S Manna, Amaresh Sinha, Ramkrishna Sadhukhan, Current Microbiology Antitumor ActivityEngineeringBiotechnologyMicrobiologyBiomolecular Engineering	1995	161
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis Viktor Todorović, Zhi Su, C. Brent Putman, Scientific Reports	2019	67
The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface Ramkrishna Sadhukhan, Ganes C. Sen, Ramaswamy Ramchandran, Proceedings of the National Academy of Sciences Protein SecretionCleavage-secretion ProcessCellular PhysiologyProtein FoldingCell Surface	1998	61
Unaltered Cleavage and Secretion of Angiotensin-converting Enzyme in Tumor Necrosis Factor-α-converting Enzyme-deficient Mice Ramkrishna Sadhukhan, Kizhakkekara R. Santhamma, P. Linga Reddy, Journal of Biological Chemistry	1999	50
Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation Li Zhou, Viktor Todorović, Steve Kakavas, Journal of Biological Chemistry	2017	41
Different Glycosylation Requirements for the Synthesis of Enzymatically Active Angiotensin-converting Enzyme in Mammalian Cells and Yeast Ramkrishna Sadhukhan, Indira Sen Journal of Biological Chemistry	1996	38
<scp>IL</scp>‐36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis Zhi Su, Stephanie Paulsboe, J. Wetter, Experimental Dermatology	2018	32
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode M.A. Argiriadi, Anna Ericsson, Christopher M. Harris, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural Sciences2,4-Diaminopyrimidine Mk2 InhibitorsMedicine	2009	26
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches M.A. Argiriadi, Lorenzo Benatuil, I. Dubrovska, BMC Molecular and Cell Biology	2019	26
Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration Kun Ding, Lucia J. Eaton, Diana R. Bowley, mAbs Translational MedicineOcular DiseaseAngiogenesisNeutralizes VegfOphthalmology	2016	24

Page 1